Galera Therapeutics-esophagitis-8thJan - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Galera Therapeutics doses first patient in Phase IIa trial of GC4419

Galera Therapeutics-esophagitis-8thJan
High magnification micrograph of herpes eosphagitis. Credit: Nephron.